androstenedione has been researched along with mdv 3100 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alyamani, M; Berk, M; Hettel, D; Sharifi, N; Zhang, A | 1 |
| Beijnen, JH; Rosing, H; van Nuland, M; van Rossum, HH; Venekamp, N; Wouters, WME | 1 |
2 other study(ies) available for androstenedione and mdv 3100
| Article | Year |
|---|---|
AR Signaling in Prostate Cancer Regulates a Feed-Forward Mechanism of Androgen Synthesis by Way of HSD3B1 Upregulation.
Topics: Androgens; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Benzamides; Cell Line, Tumor; Dehydroepiandrosterone; Gene Expression Regulation, Neoplastic; Humans; Male; Metribolone; Mice; Multienzyme Complexes; Neoplasm Transplantation; Nitriles; Orchiectomy; Phenylthiohydantoin; Progesterone Reductase; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Steroid Isomerases; Testosterone; Testosterone Congeners; Up-Regulation | 2018 |
LC-MS/MS assay for the quantification of testosterone, dihydrotestosterone, androstenedione, cortisol and prednisone in plasma from castrated prostate cancer patients treated with abiraterone acetate or enzalutamide.
Topics: Abiraterone Acetate; Androstenedione; Benzamides; Chromatography, Liquid; Dihydrotestosterone; Humans; Hydrocortisone; Male; Nitriles; Phenylthiohydantoin; Plasma; Prednisone; Prostatic Neoplasms, Castration-Resistant; Tandem Mass Spectrometry; Testosterone | 2019 |